XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets:    
Cash $ 28,386 $ 61,463
Accounts receivable, net 60,075 7,716
Inventories, net of allowances of $461,734 and $533,254, respectively 214,428 412,261
Prepaid expenses and other current assets 50,858 37,090
Total Current Assets 353,747 518,530
Operating lease- right of use asset, net 34,151
Property and equipment, net 42,970
Deposit 24,039
Goodwill 1,312,482 1,312,482
Total Assets 1,709,199 1,889,202
Current Liabilities:    
Accounts payable and accrued liabilities 722,643 309,439
Notes payable related parties and accrued interest-current 1,874,578 413,425
Notes payable unrelated party and accrued interest-current 587,355 206,712
Operating lease- current portion 37,535
Total Current Liabilities 3,184,576 967,111
Notes payable related parties and accrued interest, less current portion 821,647
Notes payable unrelated party and accrued interest, less current portion 360,446
Deferred tax liabilities -long-term 285,379 285,379
Total Long-Term Liabilities 285,379 1,467,472
Total Liabilities 3,469,955 2,434,583
Stockholders’ Equity:    
Common Stock, par value $.0001 per share, authorized 295,000,000 shares, issued and outstanding 48,826,864 shares at September 30, 2023 and December 31, 2022. 4,884 4,884
Additional paid-in capital 8,550,510 8,550,510
Accumulated deficit (10,316,152) (9,100,777)
Total Stockholders’ Deficit (1,760,756) (545,381)
Total Liabilities and Stockholders’ Deficit 1,709,199 1,889,202
Series A Preferred Stock [Member]    
Stockholders’ Equity:    
Preferred Stock, Series C, par value $1.00 per share, authorized 67 shares, issued and outstanding -0- shares
Total Stockholders’ Deficit
Series B Preferred Stock [Member]    
Stockholders’ Equity:    
Preferred Stock, Series C, par value $1.00 per share, authorized 67 shares, issued and outstanding -0- shares 2 2
Total Stockholders’ Deficit 2 2
Series C Preferred Stock [Member]    
Stockholders’ Equity:    
Preferred Stock, Series C, par value $1.00 per share, authorized 67 shares, issued and outstanding -0- shares
Total Stockholders’ Deficit